Revenues of MediXall Group, Inc. from 31 Dec 2013 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
MediXall Group, Inc. quarterly and annual Revenues in USD history and change rate from 31 Dec 2013 to 30 Sep 2024.
  • MediXall Group, Inc. Revenues for the quarter ending 30 Sep 2024 was $38,858, a 41% decline year-over-year.
  • MediXall Group, Inc. Revenues for the twelve months ending 30 Sep 2024 was $304,336, a 29% increase year-over-year.
  • MediXall Group, Inc. annual Revenues for 2023 was $309,422, a 422% increase from 2022.
  • MediXall Group, Inc. annual Revenues for 2022 was $59,268, a 67% decline from 2021.
  • MediXall Group, Inc. annual Revenues for 2021 was $180,714.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

MediXall Group, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $304,336 $38,858 -$26,677 -41% 01 Jul 2024 30 Sep 2024 10-Q 08 Sep 2025 2024 Q3
Q2 2024 $331,013 $52,839 -$18,685 -26% 01 Apr 2024 30 Jun 2024 10-Q 05 Jun 2025 2024 Q2
Q1 2024 $349,698 $118,142 +$40,276 +52% 01 Jan 2024 31 Mar 2024 10-Q 19 May 2025 2024 Q1
Q4 2023 $309,422 $94,497 +$74,254 +367% 01 Oct 2023 31 Dec 2023 10-K 27 Jan 2025 2023 FY
Q3 2023 $235,168 $65,535 +$44,769 +216% 01 Jul 2023 30 Sep 2023 10-Q 08 Sep 2025 2024 Q3
Q2 2023 $190,399 $71,524 +$61,172 +591% 01 Apr 2023 30 Jun 2023 10-Q 05 Jun 2025 2024 Q2
Q1 2023 $129,227 $77,866 +$69,959 +885% 01 Jan 2023 31 Mar 2023 10-Q 19 May 2025 2024 Q1
Q4 2022 $59,268 $20,243 +$13,215 +188% 01 Oct 2022 31 Dec 2022 10-K 27 Jan 2025 2023 FY
Q3 2022 $46,053 $20,766 +$16,993 +450% 01 Jul 2022 30 Sep 2022 10-Q 20 Jun 2024 2023 Q3
Q2 2022 $29,060 $10,352 -$156,290 -94% 01 Apr 2022 30 Jun 2022 10-Q 06 Jun 2024 2023 Q2
Q1 2022 $185,350 $7,907 +$4,636 +142% 01 Jan 2022 31 Mar 2022 10-Q 14 May 2024 2023 Q1
Q4 2021 $180,714 $7,028 01 Oct 2021 31 Dec 2021 10-K 09 Aug 2023 2022 FY
Q3 2021 $3,773 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $166,642 01 Apr 2021 30 Jun 2021 10-Q 23 Aug 2022 2022 Q2
Q1 2021 $3,271 01 Jan 2021 31 Mar 2021 10-Q 01 Aug 2022 2022 Q1
Q4 2019 $2,685 $432 01 Oct 2019 31 Dec 2019 10-K 17 Jun 2021 2020 FY
Q3 2019 $807 +$435 +117% 01 Jul 2019 30 Sep 2019 10-Q 17 Nov 2020 2020 Q3
Q2 2019 $1,114 -$59 -5% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $332 01 Jan 2019 31 Mar 2019 10-Q 16 Jun 2020 2020 Q1
Q3 2018 $372 -$9,709 -96% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $1,173 01 Apr 2018 30 Jun 2018 10-Q 02 Aug 2019 2019 Q2
Q3 2017 $10,081 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3

MediXall Group, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $309,422 +$250,154 +422% 01 Jan 2023 31 Dec 2023 10-K 27 Jan 2025 2023 FY
2022 $59,268 -$121,446 -67% 01 Jan 2022 31 Dec 2022 10-K 27 Jan 2025 2023 FY
2021 $180,714 +$180,714 01 Jan 2021 31 Dec 2021 10-K 09 Aug 2023 2022 FY
2020 $0 -$2,685 -100% 01 Jan 2020 31 Dec 2020 10-K 19 Apr 2022 2021 FY
2019 $2,685 +$827 +45% 01 Jan 2019 31 Dec 2019 10-K 17 Jun 2021 2020 FY
2018 $1,858 -$20,374 -92% 01 Jan 2018 31 Dec 2018 10-K 14 May 2020 2019 FY
2017 $22,232 01 Jan 2017 31 Dec 2017 10-K 16 May 2019 2018 FY
2013 $42,500 01 Jan 2013 31 Dec 2013 10-K 30 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.